PharmCAT: A Pharmacogenomics Clinical Annotation Tool

被引:29
|
作者
Klein, Teri E. [1 ]
Ritchie, Marylyn D. [2 ,3 ]
机构
[1] Stanford Univ, Dept Biomed Data Sci, Palo Alto, CA 94304 USA
[2] Geisinger, Biomed & Translat Informat Inst, Danville, PA USA
[3] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
关键词
RECOMMENDATIONS; NETWORK; UPDATE; BENCH; BYTE;
D O I
10.1002/cpt.928
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Implementation of genomic medicine into clinical care continues to increase in prevalence in medical centers worldwide. As defined by the National Human Genome Research Institute, Genomic medicine is an emerging medical discipline that involves using genomic information about an individual as part of their clinical care.... The genomic information utilized falls broadly into two categories: 1) highly penetrant genetic disorders and 2) pharmacogenomics. Herein, we focus on pharmacogenomics, although the Pharmacogenomics Clinical Annotation Tool (PharmCAT) tool could be extended to include other types of genetic variation.
引用
收藏
页码:19 / 22
页数:4
相关论文
共 50 条
  • [41] Clinical Pharmacogenomics: Applications in Nephrology
    Adams, Solomon M.
    Crisamore, Karryn R.
    Empey, Philip E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (10): : 1561 - 1571
  • [42] Pharmacogenomics as a Tool for Management of Drug Hypersensitivity Reactions
    Perez-Sanchez, Natalia
    Jurado-Escobar, Raquel
    Dona, Inmaculada
    Soriano-Gomis, Victor
    Moreno-Aguilar, Carmen
    Bartra, Joan
    Isidoro-Garcia, Maria
    Jose Torres, Maria
    Antonio Cornejo-Garcia, Jose
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2019, 6 (01) : 1 - 17
  • [43] Clinical Implementation of Cardiovascular Pharmacogenomics
    Pereira, Naveen L.
    Stewart, A. Keith
    MAYO CLINIC PROCEEDINGS, 2015, 90 (06) : 701 - 704
  • [44] Transporting pharmacogenomics into clinical practice
    Friedman, Scott L.
    JOURNAL OF HEPATOLOGY, 2014, 61 (01) : 1 - 2
  • [45] Will pharmacogenomics guide clinical practice?
    J Licinio
    I Alvarado
    M-L Wong
    The Pharmacogenomics Journal, 2002, 2 (2) : 71 - 71
  • [46] The clinical implications of antiretroviral pharmacogenomics
    Fox, Julie
    Boffito, Marta
    Winston, Alan
    PHARMACOGENOMICS, 2006, 7 (04) : 587 - 596
  • [47] Clinical significance of clopidogrel pharmacogenomics
    Chen, Hui
    Wu, Xiaoying
    Sun, Hong
    Yu, Lin
    Hong, Dandan
    Wang, Jianjun
    Wang, Huan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S135 - S135
  • [48] Moving pharmacogenomics into clinical practices
    Liou, Shyh-Yuh
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 54P - 54P
  • [49] Pharmacogenomics in cardiovascular clinical trials
    Shah, R
    Darne, B
    Atar, D
    Abadie, E
    Adams, KF
    Zannad, F
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 (06) : 705 - 708
  • [50] Pharmacogenomics in clinical trials: an overview
    Nogueiras-Alvarez, Rita
    FRONTIERS IN PHARMACOLOGY, 2023, 14